🔥🐔 BizChicken 🐔🔥
Companies Similar to Entero Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
BioAtla, Inc.
BA3011
Bio Atla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Their lead product candidate is BA3011, targeting various cancers.
Symbol: BCAB
Recent Price: $0.59
Industry: Biotechnology
CEO: Dr. Jay M. Short Ph.D.
Sector: Healthcare
Employees: 65
Address: 11085 Torreyana Road, San Diego, CA 92121
Phone: 858 558 0708
Last updated: 2024-12-31
Gain Therapeutics, Inc.
Site-Directed Enzyme Enhancement Therapy platform
Gain Therapeutics, Inc. is a biotechnology company developing therapies for diseases caused by protein misfolding, focusing on rare genetic diseases and neurological disorders. It utilizes its proprietary technology to discover and develop molecules targeting misfolded proteins.
Symbol: GANX
Recent Price: $2.18
Industry: Biotechnology
CEO: Mr. Gene Mack M.B.A.
Sector: Healthcare
Employees: 29
Address: 4800 Montgomery Lane, Bethesda, MD 20814
Phone: 301 500 1556
Last updated: 2024-12-31
Entero Therapeutics, Inc.
latiglutenase
First Wave Bio Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and non-systemic therapies for gastrointestinal diseases, including treatments for celiac disease, fat digestion, gastroparesis, and inflammatory bowel diseases.
Symbol: ENTO
Recent Price: $0.62
Industry: Biotechnology
CEO: Mr. James R. Sapirstein M.B.A., R.Ph.
Sector: Healthcare
Employees: 9
Address: 777 Yamato Road, Boca Raton, FL 33431
Phone: (561) 589-7020
Last updated: 2024-12-31
Halozyme Therapeutics, Inc.
ENHANZE drug delivery technology
Halozyme Therapeutics, Inc. is a biopharma technology platform company specializing in enabling subcutaneous delivery of biologics using its patented ENHANZE technology. The company operates in the United States and internationally, offering products such as Hylenex recombinant and developing treatments for various medical conditions including lymphomas and immunodeficiency disorders.
Symbol: HALO
Recent Price: $47.99
Industry: Biotechnology
CEO: Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.
Sector: Healthcare
Employees: 373
Address: 11388 Sorrento Valley Road, San Diego, CA 92121
Phone: 858 794 8889
Last updated: 2024-12-31
Kronos Bio, Inc.
entospletinib (ENTO)
Kronos Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel cancer therapeutics targeting dysregulated transcription factors. It is developing product candidates like entospletinib for acute myeloid leukemia and KB-0742 for MYC-amplified solid tumors.
Symbol: KRON
Recent Price: $0.97
Industry: Biotechnology
CEO: Dr. Norbert W. Bischofberger Ph.D.
Sector: Healthcare
Employees: 58
Address: 1300 South El Camino Real, San Mateo, CA 94402
Phone: 650 781 5200
Last updated: 2024-12-31
Lixte Biotechnology Holdings, Inc.
LB-100 series and LB-200 series
Lixte Biotechnology Holdings, Inc. is a drug discovery company leveraging biomarker technology to develop enzyme-targeting drugs for cancer, vascular, metabolic, hereditary, and neurodegenerative diseases.
Symbol: LIXT
Recent Price: $2.00
Industry: Biotechnology
CEO: Mr. Bastiaan van der Baan M.Sc.
Sector: Healthcare
Employees: 3
Address: 680 East Colorado Boulevard, Pasadena, CA 91101
Phone: 631 830 7092
Last updated: 2024-12-31
Statera Biopharma, Inc.
STAT-201, Entolimod, STAT-401, STAT-205
Statera Bio Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies to treat autoimmune diseases, cancers, and infectious diseases by rebalancing the immune system.
Symbol: STAB
Recent Price: $0.00
Industry: Biotechnology
CEO: Mr. Michael Kevin Handley
Sector: Healthcare
Employees: 46
Address: 2537 Research Boulevard, Fort Collins, CO 80526
Phone: 888 613 8802
Last updated: 2024-12-31
Astria Therapeutics, Inc.
STAR-0215
Astria Therapeutics, Inc., is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic and immunological diseases in the United States. Its lead product candidate, STAR-0215, is targeting hereditary angioedema.
Symbol: ATXS
Recent Price: $8.88
Industry: Biotechnology
CEO: Ms. Jill C. Milne Ph.D.
Sector: Healthcare
Employees: 59
Address: 100 High Street, Boston, MA 02110
Phone: 617 349 1971
Last updated: 2024-12-31
Biora Therapeutics, Inc.
oral biotherapeutics
Biora Therapeutics, Inc., a biotechnology company, focuses on developing oral biotherapeutics using ingestible smart capsules for targeted delivery in the gastrointestinal tract and needle-free delivery into the intestinal mucosa.
About | Leadership | About | Contact | Contact | Careers | Careers | About | Careers | Careers | About | About
Symbol: BIOR
Recent Price: $0.22
Industry: Biotechnology
CEO: Mr. Aditya P. Mohanty M.B.A.
Sector: Healthcare
Employees: 58
Address: 4330 La Jolla Village Drive, San Diego, CA 92122
Phone: 855 293 2639
Leadership
- Adi Mohanty, MBA, Chief Executive Officer & Board Member
- Eric d’Esparbes, Chief Financial Officer
- Robyn Hatton, Head of Human Resources
- Ariella Kelman, MD, Chief Medical Officer
- James Knight, MBA, Head of Business Development
- Clarke Neumann, JD, General Counsel and Secretary
- Paul Shabram, MBA, Head of Technical Operations
- Sharat Singh, PhD, Head of Research
- Maria (Mimi) Villanueva CPMI, PPMC, Vice President, Product Development Operations & Program Management
- Jeffrey Alter, MBA, Board Chair
- Jeffrey Ferrell, Board Member
- Jill Howe, Board Member
- Brian Kotzin, MD, Board Member
- Lynne Powell, MBA, Board Member
- Bruce Sands, MD, MS, Advisory Board Chair
- Geert D’Haens, MD, PhD, Advisory Board Member
- Brian Feagan, MD, FRCPC, Advisory Board Member
- Séverine Vermeire, MD, PhD, Advisory Board Member
- Satish Rao, MD, PhD, Advisory Board Chair
- William Chey, MD, Advisory Board Member
- Anthony Lembo, MD, Advisory Board Member
- Mark Pimentel, MD, Advisory Board Member
Last updated: 2024-12-31
89bio, Inc.
pegozafermin
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for liver and cardio-metabolic diseases, primarily through its lead product candidate, pegozafermin, designed to treat nonalcoholic steatohepatitis and severe hypertriglyceridemia.
Symbol: ETNB
Recent Price: $7.87
Industry: Biotechnology
CEO: Mr. Rohan Palekar
Sector: Healthcare
Employees: 70
Address: 142 Sansome Street, San Francisco, CA 94104
Phone: 415 432 9270
Last updated: 2024-12-31
Belite Bio, Inc
LBS-008
Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics for age-related macular degeneration and Stargardt diseases. Its lead product candidate, LBS-008, is in phase 3 clinical trials.
Symbol: BLTE
Recent Price: $61.97
Industry: Biotechnology
CEO: Dr. Yu-Hsin Lin M.B.A., Ph.D.
Sector: Healthcare
Employees: 20
Address: 5820 Oberlin Drive, San Diego, CA 92121
Phone: 858-246-6240
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
Galectin Therapeutics Inc.
belapectin (GR-MD-02)
Galectin Therapeutics Inc. engages in research and development of therapies for fibrotic, cancer, and other diseases, with a focus on developing galectin-3 inhibitors like belapectin.
Symbol: GALT
Recent Price: $1.10
Industry: Biotechnology
CEO: Mr. Joel Lewis
Sector: Healthcare
Employees: 14
Address: 4960 Peachtree Industrial Boulevard, Norcross, GA 30071
Phone: 678 620 3186
Last updated: 2024-12-31
Inozyme Pharma, Inc.
INZ-701
Inozyme Pharma, Inc. is a biopharmaceutical company focused on the development of therapeutics for rare disease conditions involving abnormal mineralization, particularly targeting ENPP1 and ABCC6 deficiencies.
Symbol: INZY
Recent Price: $2.82
Industry: Biotechnology
CEO: Dr. Douglas A. Treco Ph.D.
Sector: Healthcare
Employees: 59
Address: 321 Summer Street, Boston, MA 02210
Phone: 857 330 4340
Leadership
- Doug Treco, Ph.D., CEO, Chairman of Board of Directors
- Gayle Gironda, Senior Vice President and Chief People Officer
- Kurt Gunter, M.D., Senior Vice President and Chief Medical Officer
- Soojin Kim, Ph.D., Senior Vice President and Chief Technical Operations Officer
- Yves Sabbagh, Ph.D., Senior Vice President and Chief Scientific Officer, Chair of the Scientific Advisory Board
- Sanjay S. Subramanian, M.S., MBA, Senior Vice President and Chief Financial Officer
- Matt Winton, Ph.D., Senior Vice President and Chief Operating Officer
- Axel Bolte, MBA, Co-founder, Senior Advisor and Member of Board of Directors
- David Thompson, M.A., M.S., Ph.D., Senior Advisor, Member of Scientific Advisory Board
- Sarah Bhagat, Ph.D., Director
- Reinaldo M. Diaz, MBA, Director
- Martin Edwards M.D., MBA, Director
- Erik Harris, MBA, Director
- Rob Hopfner, Rph, Ph.D., MBA, Director
- Edward Mathers, Director
- Lynne Sullivan, MST, Director
Last updated: 2024-12-31
Onconetix, Inc.
Entadfi
Onconetix, Inc. is a biotechnology and pharmaceutical company focused on developing and commercializing transformative therapies to address global health challenges. The company’s products include Entadfi for benign prostatic hyperplasia and various innovative vaccine candidates.
Symbol: ONCO
Recent Price: $0.44
Industry: Biotechnology
CEO: Dr. Ralph Schiess Ph.D.
Sector: Healthcare
Employees: 12
Address: 201 East Fifth Street, Cincinnati, OH 45202
Phone: 513 620 4101
Last updated: 2024-12-31
Palisade Bio, Inc.
LB1148
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing oral therapies targeting serious diseases related to the breakdown of the gastrointestinal mucosal barrier. Their lead product, LB1148, is designed to protect gut integrity during intestinal stress.
Symbol: PALI
Recent Price: $1.70
Industry: Biotechnology
CEO: Mr. J. D. Finley
Sector: Healthcare
Employees: 9
Address: 5800 Armada Drive, Carlsbad, CA 92008
Phone: 858 704 4900
Last updated: 2024-12-31
Entrada Therapeutics, Inc.
ENTR-601-44
Entrada Therapeutics, Inc. develops endosomal escape vehicle (EEV) therapeutics for treating neuromuscular diseases, with a lead product candidate ENTR-601-44 in preclinical trials for Duchenne muscular dystrophy and myotonic dystrophy type 1.
About | Contact | Contact | Careers | Careers | Careers | About | About | Careers | Careers | Careers | Careers | Careers | Careers | About
Symbol: TRDA
Recent Price: $17.37
Industry: Biotechnology
CEO: Mr. Dipal Doshi
Sector: Healthcare
Employees: 168
Address: 6 Tide Street, Boston, MA 02210
Phone: 857 520 9158
Last updated: 2024-12-31
Aligos Therapeutics, Inc.
ALG-010133
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for viral and liver diseases, with a focus on chronic hepatitis B and non-alcoholic steatohepatitis.
Careers | About | Management | Management | Contact | About | About
Symbol: ALGS
Recent Price: $40.47
Industry: Biotechnology
CEO: Dr. Lawrence M. Blatt MBA, Ph.D.
Sector: Healthcare
Employees: 68
Address: One Corporate Drive, South San Francisco, CA 94080
Phone: 800 466 6059
Last updated: 2024-12-31
Enanta Pharmaceuticals, Inc.
N/A
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases, with targets including respiratory syncytial virus, SARS-Co V-2, human metapneumovirus, and hepatitis B virus.
About | Leadership | Directors | Contact | Careers | Careers | Culture | About | About | About
Symbol: ENTA
Recent Price: $5.85
Industry: Biotechnology
CEO: Dr. Jay R. Luly Ph.D.
Sector: Healthcare
Employees: 145
Address: 500 Arsenal Street, Watertown, MA 02472
Phone: 617 607 0800
Leadership
- Jay R. Luly, Ph.D., President, Chief Executive Officer and Director
- Tara L. Kieffer, Ph.D., Chief Product Strategy Officer
- Matthew P. Kowalsky, J.D., Chief Legal Officer
- Brendan Luu, Chief Business Officer
- Paul J. Mellett, Chief Financial and Administrative Officer
- Yat Sun Or, Ph.D., Chief Scientific Officer
- Scott T. Rottinghaus, M.D., Chief Medical Officer
- Bruce L.A. Carter, Ph.D., Chairman of the Board
- Mark G. Foletta, Board Member
- Yujiro S. Hata, Board Member
- Kristine Peterson, Board Member
- Lesley Russell, MBChB, MRCPb, Board Member
- Terry Vance, Board Member
Last updated: 2024-12-31
Ventyx Biosciences, Inc.
VTX958
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule product candidates for the treatment of inflammatory diseases and autoimmune disorders. Key products include VTX958 for immune-mediated diseases, VTX002 for ulcerative colitis, and VTX2735 for systemic inflammatory diseases.
Symbol: VTYX
Recent Price: $2.23
Industry: Biotechnology
CEO: Dr. Raju S. Mohan Ph.D.
Sector: Healthcare
Employees: 73
Address: 662 Encinitas Boulevard, Encinitas, CA 92024
Phone: 760 593 4832
Last updated: 2024-12-31